US Stock MarketDetailed Quotes

GILD Gilead Sciences

Watchlist
  • 117.410
  • +1.370+1.18%
Close Mar 7 16:00 ET
  • 117.000
  • -0.410-0.35%
Post 20:01 ET
146.22BMarket Cap308.97P/E (TTM)

Gilead Sciences Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Mar 9, 2025

Based on 22 analysts giving stock ratings to Gilead Sciences in the past 3 months

Strong Buy

  • Buy

    81.82%

  • Hold

    18.18%

  • Sell

    0.00%

Price Target

Updated: Mar 9, 2025

The average Gilead Sciences stock price target is 116.88 with a max estimate of 140.00 and a min estimate of 99.00

Review Gilead Sciences earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MARA Holdings
MARA
+6.16%
Ecopetrol
EC
+3.44%
Oracle
ORCL
+2.80%
Apple
AAPL
+1.59%
Coinbase
COIN
+1.53%

Unlock the Full List

Analysis

Analyst Rating

Updated: Mar 9, 2025

Strong Buy

  • Buy

    81.82%

  • Hold

    18.18%

  • Sell

    0.00%

Price Target

Updated: Mar 9, 2025

Investment Theme Mpox (monkeypox)
Mpox (monkeypox)
Intraday+1.64%
Cancer Research
Cancer Research
Intraday+1.51%
CAR-T Therapy
CAR-T Therapy
Intraday+1.47%